RPC vs. ZVRA
RPC (Ridgepost Capital, Inc) and ZVRA (Zevra Therapeutics Inc.) are both stocks. RPC operates in Asset Management (Financial Services), while ZVRA operates in Biotechnology (Healthcare). Over the past 3 years, RPC returned -9.77%/yr vs 29.56%/yr for ZVRA. At a 0.25 correlation, their price movements are largely independent.
Performance
RPC vs. ZVRA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RPC achieves a -20.36% return, which is significantly lower than ZVRA's 22.32% return.
RPC
- 1D
- -5.61%
- 1M
- -3.15%
- YTD
- -20.36%
- 6M
- -20.60%
- 1Y
- -22.10%
- 3Y*
- -9.77%
- 5Y*
- —
- 10Y*
- —
ZVRA
- 1D
- 0.74%
- 1M
- 9.05%
- YTD
- 22.32%
- 6M
- 25.69%
- 1Y
- 23.56%
- 3Y*
- 29.56%
- 5Y*
- -0.64%
- 10Y*
- -20.77%
RPC vs. ZVRA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RPC Ridgepost Capital, Inc | -20.36% | -21.16% | 25.17% | -3.02% | -23.07% | 15.73% |
ZVRA Zevra Therapeutics Inc. | 22.32% | 7.43% | 27.33% | 42.70% | -47.30% | -10.57% |
Correlation
The correlation between RPC and ZVRA is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2021 | 0.25 |
Fundamentals
RPC:
$907.93M
ZVRA:
$660.13M
RPC:
$0.20
ZVRA:
$2.16
RPC:
38.27
ZVRA:
5.07
RPC:
2.95
ZVRA:
5.15
RPC:
2.58
ZVRA:
3.21
RPC:
$304.70M
ZVRA:
$122.29M
RPC:
$192.25M
ZVRA:
$104.94M
RPC:
$103.82M
ZVRA:
$149.15M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RPC vs. ZVRA — Risk / Return Rank
RPC
ZVRA
RPC vs. ZVRA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ridgepost Capital, Inc (RPC) and Zevra Therapeutics Inc. (ZVRA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RPC | ZVRA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.93 | ||
| Sortino ratioReturn per unit of downside risk | -1.50 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.13 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.49 | 0.54 | -1.03 |
| Martin ratioReturn relative to average drawdown | -0.91 | 0.95 | -1.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RPC | ZVRA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.53 | 0.40 | -0.93 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.01 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.26 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.22 | -0.27 | +0.05 |
Drawdowns
RPC vs. ZVRA - Drawdown Comparison
The maximum RPC drawdown since its inception was -51.53%, smaller than the maximum ZVRA drawdown of -99.27%. Use the drawdown chart below to compare losses from any high point for RPC and ZVRA.
Loading charts...
Drawdown Indicators
| RPC | ZVRA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.53% | -99.27% | +47.74% |
Max Drawdown (1Y)Largest decline over 1 year | -45.47% | -43.47% | -2.00% |
Max Drawdown (3Y)Largest decline over 3 years | -50.24% | -43.47% | -6.77% |
Max Drawdown (5Y)Largest decline over 5 years | — | -74.01% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.85% | — |
Current DrawdownCurrent decline from peak | -45.40% | -97.10% | +51.70% |
Average DrawdownAverage peak-to-trough decline | -26.62% | -86.39% | +59.77% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.45% | 24.82% | -0.37% |
Volatility
RPC vs. ZVRA - Volatility Comparison
The current volatility for Ridgepost Capital, Inc (RPC) is 11.17%, while Zevra Therapeutics Inc. (ZVRA) has a volatility of 17.46%. This indicates that RPC experiences smaller price fluctuations and is considered to be less risky than ZVRA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RPC | ZVRA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.17% | 17.46% | -6.29% |
Volatility (6M)Calculated over the trailing 6-month period | 35.49% | 36.13% | -0.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.79% | 59.82% | -18.03% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.26% | 60.14% | -22.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.26% | 81.32% | -44.06% |
Dividends
RPC vs. ZVRA - Dividend Comparison
RPC's dividend yield for the trailing twelve months is around 1.97%, while ZVRA has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
RPC Ridgepost Capital, Inc | 1.97% | 1.50% | 1.09% | 1.25% | 0.84% |
ZVRA Zevra Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RPC vs. ZVRA - Financials Comparison
This section allows you to compare key financial metrics between Ridgepost Capital, Inc and Zevra Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RPC and ZVRA have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ZVRA has higher volatility (17.46%) compared to RPC (11.17%). In terms of maximum drawdown, RPC dropped -51.53% vs ZVRA's -99.27%.
ZVRA currently has the higher Sharpe Ratio (0.40 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RPC and ZVRA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer